The move toward using the Digital Application Dataset Integration (DADI) project for the initial implementation of IDMP-based regulatory data submissions offers both opportunities and challenges for pharmaceutical organizations.
Renato Rjavec
Advertisement
Renato Rjavec is director of product management at Amplexor Life Sciences.
Articles by Renato Rjavec
Advertisement
Latest Updated Articles
What DADI Means for the Pharmaceutical IndustryMay 2nd 2022
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Writing the Biological Script: Scaling DNA Manufacturing for the Next Generation of Therapeutics
2
FDA Approves Pfizer’s Breast Cancer Treatment
3
Pharma Fundamentals: Hold Times in Biopharmaceuticals
4
Thermo Fisher's Kane Says AI Is Reshaping How CDMOs Add Value
5